Pear Therapeutics

Amanda Galgay

Amanda is a corporate communications leader with deep experience in the biotech and life sciences industry. Currently she leads investor relations and corporate communications on behalf of Pear Therapeutics, the first company to receive FDA authorization for a prescription digital therapeutic.

Prior to this role, Amanda led employee engagement, branding, and community relations for Vertex Pharmaceuticals, a company with an award-winning corporate culture and engagement program. She also oversaw corporate and financial communications at Biogen, during a time of double-digit growth for the company.

Amanda received B.A. degrees in biology and political science, and an M.A. in Journalism, from the University of Missouri-Columbia.

Back